Guangxi Liuzhou Pharm Co Ltd (603368) — Capital Reinvestment Ratio
Guangxi Liuzhou Pharm Co Ltd (603368) has a Capital Reinvestment Ratio of 0.81x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥45.64 Million) in capital expenditures (CN¥36.80 Million). See 603368 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangxi Liuzhou Pharm Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Guangxi Liuzhou Pharm Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check 603368 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Guangxi Liuzhou Pharm Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see 603368 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | CN¥838.51 Million | CN¥147.87 Million | ▼ -39.4% |
| 2023 | 0.29x | CN¥594.41 Million | CN¥172.94 Million | ▼ -19.6% |
| 2022 | 0.36x | CN¥506.43 Million | CN¥183.28 Million | ▼ -54.4% |
| 2021 | 0.79x | CN¥332.88 Million | CN¥264.04 Million | ▲ +101.4% |
| 2020 | 0.39x | CN¥664.69 Million | CN¥261.81 Million | ▼ -34.8% |
| 2019 | 0.60x | CN¥412.91 Million | CN¥249.54 Million | ▼ -95.0% |
| 2018 | 12.18x | CN¥22.30 Million | CN¥271.61 Million | ▲ +936.7% |
| 2016 | 1.17x | CN¥108.39 Million | CN¥127.33 Million | ▼ -64.7% |
| 2013 | 3.33x | CN¥22.33 Million | CN¥74.31 Million | ▲ +1472.1% |
| 2012 | 0.21x | CN¥60.51 Million | CN¥12.81 Million | ▼ -23.2% |
| 2011 | 0.28x | CN¥133.38 Million | CN¥36.78 Million | — |